Home > Boards > US Listed > Cannabis >

Silver Spike Acquisition Corp II (SPKBU)

Add SPKBU Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 3/14/2021 12:15:40 PM - Followers: 0 - Board type: Free - Posts Today: 0


Cannabis SPAC Silver Spike Acquisition Corp II Raises $250 Million in NASDAQ IPO

March 11, 2021 at 10:30 am


Silver Spike Acquisition Corp II Announces Pricing of $250 Million Initial Public Offering

NEW YORK, March 11, 2021–(BUSINESS WIRE)–Silver Spike Acquisition Corp II (the “Company”) announced today that it priced its initial public offering of 25,000,000 units at $10.00 per unit. The units are expected to be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “SPKBU” beginning on March 11, 2021. Each unit consists of one Class A ordinary share and one-fourth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on Nasdaq under the symbols “SPKB” and “SPKBW,” respectively.

The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on businesses in the cannabis industry that are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate. The management team and board of directors are composed of veteran cannabis and finance industry executives and founders, including Scott Gordon, founder and CEO of the Company, who began investing in the cannabis industry in 2014 and in 2016 co-founded Egg Rock Holdings, parent company of the Papa & Barkley family of cannabis products with related subsidiary assets in manufacturing, processing and logistics and served as its Chairman until 2019; and Dr. Orrin Devinsky, director of the Company, who is the director of the NYU Langone Comprehensive Epilepsy Center and is a Professor of Neurology, Neuroscience, Psychiatry and Neuroscience at the NYU School of Medicine and who, since 2016 has served as the Chair of the Medical Advisory Board at Tilray, a pharmaceutical and cannabis company.

Credit Suisse and Stifel are acting as joint book-running managers of the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,750,000 units at the initial public offering price to cover over-allotments, if any.


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SPKBU News: Current Report Filing (8-k) 06/04/2021 04:16:03 PM
SPKBU News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 05/17/2021 04:01:18 PM
SPKBU News: Current Report Filing (8-k) 05/03/2021 06:06:56 AM
SPKBU News: Statement of Ownership (sc 13g) 03/25/2021 07:02:38 PM
SPKBU News: Current Report Filing (8-k) 03/23/2021 05:23:31 PM
No posts yet. Be the first!
Consent Preferences